About the Authors
- Fei Xiao
-
Contributed equally to this work with: Fei Xiao, Isabel Fofana
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France
- Isabel Fofana
-
Contributed equally to this work with: Fei Xiao, Isabel Fofana
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France
- Laura Heydmann
-
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France
- Heidi Barth
-
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France, Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- Eric Soulier
-
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France
- François Habersetzer
-
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France, Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- Michel Doffoël
-
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France, Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- Jens Bukh
-
Affiliation Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Hvidovre Hospital and Department of International Health, Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Arvind H. Patel
-
Affiliation MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom
- Mirjam B. Zeisel
-
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France
- Thomas F. Baumert
-
* E-mail: Thomas.Baumert@unistra.fr
Affiliations Inserm, U1110, Strasbourg, France, Université de Strasbourg, Strasbourg, France, Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg, Strasbourg, France, Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
Competing Interests
I have read the journal's policy and have the following conflicts: Inserm Transfer and the University of Strasbourg have filed patent applications on host-targeting entry inhibitors for prevention and treatment of HCV infection. Thomas F. Baumert serves as scientific advisor for Biotest and Vironexx. This does not alter our adherence to all PLOS policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: TFB FX IF. Performed the experiments: FX IF LH ES. Analyzed the data: FX IF LH HB ES FH MD MBZ TFB. Contributed reagents/materials/analysis tools: JB AHP. Wrote the paper: FX IF MBZ TFB.